Institute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
Institute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
Beijing Hebabiz Biotechnology Co. Ltd., Beijing, China
Institute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
National and Region joint Engineering Center for Anticancer Drug Development, Guangxi Hebabiz Pharmaceutical Co. Ltd., Qinzhou, China
Institute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China
National and Region joint Engineering Center for Anticancer Drug Development, Guangxi Hebabiz Pharmaceutical Co. Ltd., Qinzhou, China
National and Region joint Engineering Center for Anticancer Drug Development, Guangxi Hebabiz Pharmaceutical Co. Ltd., Qinzhou, China
MOE Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University, Wuhan, China
Copyright © 2018 Yuxin Chen, Qigui Mo, Baibo Xie, Bingxin Ma, Xinyu Zang, Gao Zhou, Linyou Cheng, James Hua Zhou, Youwei Wang et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Chen, Y. , Mo, Q. , Xie, B. , Ma, B. , Zang, X. , Zhou, G. , Cheng, L. , Zhou, J. and Wang, Y. (2018) Hepatoprotective Activity of Yigan Mingmu Oral Liquid against Isoniazid/Rifampicin-Induced Liver Injuries in Rats.
Chinese Medicine,
9, 165-178. doi:
10.4236/cm.2018.94010.